Bochum, Germany

Michael Dorschug


Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 250(Granted Patents)


Company Filing History:


Years Active: 1991-2000

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Dorschug

Introduction

Michael Dorschug is a notable inventor based in Bochum, Germany. He has made significant contributions to the field of diabetes treatment through his innovative work on insulin derivatives. With a total of 7 patents to his name, Dorschug continues to push the boundaries of medical science.

Latest Patents

Among his latest patents are A.sup.21 and B.sup.30, which focus on modified insulin derivatives. These derivatives have an altered structure that provides improved stability in weakly acidic aqueous mediums. They also feature a special action profile, making them particularly effective for the treatment of diabetes mellitus. Additionally, he has developed a process for the specific hydrolysis of preproinsulin analogs, utilizing clostripain and, if necessary, carboxypeptidase B to yield the corresponding insulins.

Career Highlights

Dorschug is currently associated with Hoechst Aktiengesellschaft, a company known for its advancements in pharmaceuticals and biotechnology. His work has been instrumental in developing new therapeutic options for diabetes patients, showcasing his commitment to improving healthcare outcomes.

Collaborations

Throughout his career, Dorschug has collaborated with esteemed colleagues such as Gerhard Seipke and Ranier Obermeier. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Michael Dorschug's contributions to the field of diabetes treatment through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical science, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…